Brandywine Global Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-226,345
| Closed | -$6.6M | – | 744 |
|
|
2021
Q4 | $6.6M | Hold |
226,345
| – | – | 0.05% | 350 |
|
|
2021
Q3 | $6.04M | Sell |
226,345
-18,088
| -7% | -$482K | 0.05% | 356 |
|
|
2021
Q2 | $7.53M | Sell |
244,433
-8,556
| -3% | -$263K | 0.06% | 332 |
|
|
2021
Q1 | $6.62M | Sell |
252,989
-12,562
| -5% | -$329K | 0.05% | 366 |
|
|
2020
Q4 | $6.68M | Buy |
265,551
+40,948
| +18% | +$1.03M | 0.06% | 326 |
|
|
2020
Q3 | $4.68M | Buy |
+224,603
| New | +$4.68M | 0.05% | 331 |
|
|
2017
Q2 | – | Sell |
-83,985
| Closed | -$2.63M | – | 936 |
|
|
2017
Q1 | $2.63M | Sell |
83,985
-2,996
| -3% | -$93.8K | 0.02% | 543 |
|
|
2016
Q4 | $2.2M | Sell |
86,981
-26,899
| -24% | -$679K | 0.01% | 566 |
|
|
2016
Q3 | $2.82M | Sell |
113,880
-3,018
| -3% | -$74.7K | 0.02% | 524 |
|
|
2016
Q2 | $2.38M | Sell |
116,898
-28,777
| -20% | -$586K | 0.02% | 531 |
|
|
2016
Q1 | $2.22M | Sell |
145,675
-21,845
| -13% | -$333K | 0.01% | 527 |
|
|
2015
Q4 | $2.25M | Buy |
167,520
+158,680
| +1,795% | +$2.13M | 0.01% | 543 |
|
|
2015
Q3 | $125K | Buy |
8,840
+900
| +11% | +$12.7K | ﹤0.01% | 763 |
|
|
2015
Q2 | $135K | Buy |
+7,940
| New | +$135K | ﹤0.01% | 773 |
|